DESCRIPTION. SYMBYAX (olanzapine and fluoxetine HCl capsules) combines an atypical antipsychotic and a selective serotonin reuptake inhibitor, olanzapine (the active ingredient in Zyprexa, and Zyprexa Zydis) and fluoxetine hydrochloride (the active ingredient in Prozac, Prozac Weekly, and Sarafem). Zyprexa is the brand name of olanzapine, a prescription drug used to treat schizophrenia and bipolar disorder. It's also used to treat depression when used with other medications. Geriatric patients may be more likely to have problems associated with increased anticholinergic activity, orthostatic hypotension, movement disorders, and CNS depression with olanzapine use vs. younger adults. updated 11/2014 [mwm-aal-display] Yes, it’s a huge problem. This is a difficult problem to be sure, one that almost everyone getting medication treatment has to consider in some way, because: Describes the medication olanzapine (Zyprexa, Zydis, Relprevv), a drug used for treating patients with schizophrenia and manic episodes associated with bipolar I disorder and some types of depression. Physical Incompatibility Information — Olanzapine for injection should be reconstituted only with Sterile Water for Injection. Olanzapine for injection should not be combined in a syringe with diazepam injection because precipitation occurs when these products are mixed. Medical uses. Metformin is primarily used for type 2 diabetes, but is also used in polycystic ovary syndrome. Outcomes appear to be improved even in those with some degree of kidney disease, heart failure, or liver problems. The sedative effects of olanzapine may be most evident during the initial days of treatment. Because olanzapine has the potential to impair cognitive and motor skills, patients should be advised to use caution when driving or operating machinery or performing other tasks that require mental alertness until they know how the drug affects them. The principal side effect of olanzapine is weight gain, which may be profound in some cases and/or associated with derangement in the blood lipid and blood sugar profiles (see section metabolic effects). A sad and troubling case to be sure. What seems less obvious is the role of a withdrawal syndrome in Sally’s symptoms. While exact dates are not given, apparently about 2 months elapse between the complete termination of olanzapine administration and the onset of symptoms.